Skyhawk Therapeutics, Inc.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Skyhawk Therapeutics, Inc.
RECRUITINGPhase 2 / Phase 3NCT07378644
Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease
The goal of this clinical trial is to test if the drug SKY-0515, an oral medication, can lower harmful proteins linked to Huntington's Disease (HD) and improve the symptoms of...
Sponsor: Skyhawk Therapeutics, Inc.Enrolling: 4002 locations
Huntington Disease
RECRUITINGPhase 2 / Phase 3NCT06873334
Study of SKY-0515 for Safety, Efficacy, and Pharmacodynamics in Participants With Huntington's Disease
The goal of this clinical trial is to test if the drug SKY-0515, an oral medication, can lower harmful proteins linked to Huntington's Disease (HD) and improve the symptoms of...
Sponsor: Skyhawk Therapeutics, Inc.Enrolling: 12011 locations
Huntington DiseaseHuntingtons Disease